Kooth plc (AIM:KOO)
London · Delayed Price · Currency is GBP · Price in GBX 183.50
+15.00 (8.90%)
Sep 25, 2026, 5:15 PM GMT
Kooth Revenue
Kooth had revenue of 30.82M GBP in the half year ending June 30, 2026, a decrease of -5.15%. This brings the company's revenue in the last twelve months to 62.02M, down -6.51% year-over-year. In the year 2025, Kooth had annual revenue of 63.29M, down -5.18%.
Revenue (ttm)
62.02M
Revenue Growth
-6.51%
P/S Ratio
1.07
Revenue / Employee
111.95K
Employees
554
Market Cap
66.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.29M | -3.46M | -5.18% |
| Dec 31, 2024 | 66.74M | 33.41M | 100.21% |
| Dec 31, 2023 | 33.34M | 13.22M | 65.69% |
| Dec 31, 2022 | 20.12M | 3.44M | 20.61% |
| Dec 31, 2021 | 16.68M | 3.67M | 28.20% |
| Dec 31, 2020 | 13.01M | 4.35M | 50.27% |
| Dec 31, 2019 | 8.66M | 2.47M | 39.80% |
| Dec 31, 2018 | 6.19M | 1.29M | 26.37% |
| Dec 31, 2017 | 4.90M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.25B |
| GSK plc | 33.20B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| ECO Animal Health Group | 87.53M |
| Shield Therapeutics | 44.19M |
| Venture Life Group | 35.17M |
| Bioventix | 12.54M |
Kooth News
- 1 year ago - AIM Market Roundup: Caledonian Holdings, Deltic Energy, Kooth - The Armchair Trader
- 1 year ago - Small Cap Stocks: Armadale, Deltic Energy, Kooth - The Armchair Trader